Friedlander ML - Search Results

1

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry.

Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL. Phillips KA, et al. Among authors: friedlander ml. J Clin Oncol. 2005 Jul 20;23(21):4679-86. doi: 10.1200/JCO.2005.03.002. Epub 2005 Apr 25. J Clin Oncol. 2005. PMID: 15851764

2

Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer.

Phillips KA, Friedlander M, Olver I, Evans B, Smith J, Fitzharris B, McCrystal M, Joughin J, Bishop J. Phillips KA, et al. Aust N Z J Med. 1995 Aug;25(4):337-43. doi: 10.1111/j.1445-5994.1995.tb01899.x. Aust N Z J Med. 1995. PMID: 8540875 Clinical Trial.

3

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.

Millward MJ, Bishop JF, Friedlander M, Levi JA, Goldstein D, Olver IN, Smith JG, Toner GC, Rischin D, Bell DR. Millward MJ, et al. J Clin Oncol. 1996 Jan;14(1):142-8. doi: 10.1200/JCO.1996.14.1.142. J Clin Oncol. 1996. PMID: 8558189 Clinical Trial.

4

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.

Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, Suthers G, Haan E, Tucker K. Meiser B, et al. J Clin Oncol. 2000 Jun;18(11):2250-7. doi: 10.1200/JCO.2000.18.11.2250. J Clin Oncol. 2000. PMID: 10829045

5

A decision aid for women at increased risk for ovarian cancer.

Tiller K, Meiser B, Reeson E, Tucker M, Andrews L, Gaff C, Kirk J, Phillips KA, Friedlander M. Tiller K, et al. Int J Gynecol Cancer. 2003 Jan-Feb;13(1):15-22. doi: 10.1046/j.1525-1438.2003.13018.x. Int J Gynecol Cancer. 2003. PMID: 12631214

6

Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.

Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL. Phillips KA, et al. Among authors: friedlander ml. J Clin Oncol. 2004 Feb 15;22(4):699-705. doi: 10.1200/JCO.2004.07.062. J Clin Oncol. 2004. PMID: 14966094

7

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer.

Rischin D, Phillips KA, Friedlander M, Harnett P, Quinn M, Richardson G, Martin A. Rischin D, et al. Gynecol Oncol. 2004 May;93(2):417-21. doi: 10.1016/j.ygyno.2004.01.037. Gynecol Oncol. 2004. PMID: 15099955 Clinical Trial.

8

Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort.

Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, McLachlan SA, Lindeman GJ, McKay MJ, Friedlander ML, Hopper JL; kConFab Investigators. Phillips KA, et al. Among authors: friedlander ml. Fam Cancer. 2005;4(2):105-13. doi: 10.1007/s10689-004-6129-x. Fam Cancer. 2005. PMID: 15951960

9

Obesity and outcomes in premenopausal and postmenopausal breast cancer.

Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA. Loi S, et al. Among authors: friedlander ml. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91. doi: 10.1158/1055-9965.EPI-05-0042. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030102

10

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA, Beith J, Boyle F, Friedlander ML. Thewes B, et al. Among authors: friedlander ml. Lancet Oncol. 2005 Aug;6(8):581-8. doi: 10.1016/S1470-2045(05)70254-0. Lancet Oncol. 2005. PMID: 16054569 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

351 results

Search Page